薬理と治療

Volume 48, Issue 9, 2020
Volumes & issues:
-
扉・目次
-
-
-
TOPIC 第19回CRCと臨床試験のあり方を考える会議 2019 in YOKOHAMA
-
- <シンポジウム2>みなで進めるオーファンドラッグ開発 いいことばかりじゃないけれど,そんな時こそ
-
-
- <シンポジウム13>がんゲノム診療 —いよいよゲノム情報に基づくがん医療が保険診療に—
-
-
-
ORIGINAL ARTICLES
-
-
バンコマイシンと広域抗菌薬併用における急性腎障害発生率の比較検討
48巻9号(2020);View Description
Hide Description
Background Empirical antimicrobial therapy in the treatment of infectious diseases can target both methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa, often with a combination of broad-spectrum antimicrobials and vancomycin(VCM). Recently, it was reported that VCM causes acute kidney injury (AKI)when used in combination with tazobactam -piperacillin(TAZ/PIPC). While VCM is also used in combination with meropenem (MEPM)and cefepime(CFPM), there have been no reports of AKI in these groups of patients according to a comparison among these three groups during the same period in Japan. Methods In this study, we compared the incidence of AKI among the TAZ╱PIPC group, MEPM group, and CFPM group, all of which are used in combination with VCM. The subjects were patients who used the combination of VCM and each antimicrobial from April 2015 to March 2017 in Fukuoka University Hospital. Results The incidence of AKI was 29.7% in the TAZ╱PIPC group, which was significantly higher than that in the other groups(P<0.01). The average occurrence of AKI was 3.4 days (median: 3 days)after the start of combination therapy. Conclusions The present findings suggest that when VCM is administered with TAZ╱PIPC in combination, not only should the blood concentration of VCM be noted, but the renal function should also be closely monitored early after the start of administration. -
実験大腸ガン発癌過程におけるDNA 合成系酵素の役割
48巻9号(2020);View Description
Hide Description
Background A high incidence of adenocarcinomas in colorectum can be induced by weekly subcutaneous injection of 1,2-dimethylhydrazine in rats. Administration of dextran sulfate sodium subsequent to a single intraperitoneal injection of azoxymethane can induce chronic ulcerative colitis in mice, resulting in an increase in incidence of high-grade dysplasia and adenocarcinomas of colorectum. Thymidylate synthase and thymidine kinase, key enzymes in the de novo and salvage pathways for pyrimidine nucleotide synthesis, respectively, are highly active in rapidly proliferating tissues. Methods In the present study, we investigated the roles of these enzymes in colorectal carcinogenesis in two experimental animal model series. Results Well and poorly differentiated adenocarcinomas showed high activity of thymidine kinase in distal colon and high activity of thymidylate synthase in proximal colon in rats, respectively. Colorectal carcinogenesis developed with the increasing duration of chemically induced diarrhea in carcinogen-pretreated mice. On the contrary, sulphasalazine, anti-ulcerative colitis drug, markedly reduced the tumorous regions with high-grade dysplasia in the colorectum of mice. Conclusions These two isolated animal models may provide valuable insight into the mechanisms involved in colorectal carcinogenesis; i.e. repeated carcinogen exposure or repeated mucosal necrosis-regeneration in ulcerative colitis facilitates colorectal carcinogenesis. -
野草成分含有製品“ふし自慢 塗るタイプ”の使用が健常者の膝や肩,腰の違和感に及ぼす影響―ランダム化プラセボ対照二重盲検並行群間比較試験―
48巻9号(2020);View Description
Hide Description
Objective This study aimed to examine the effects of“Fushi-jiman(gel type)”on the knees, shoulders, and/or waist joints in healthy Japanese adult subjects“. Fushi-jiman(gel type)”contains multiple wild plant components, such as glucosamine hydrochloride, sodium chondroitin sulfate, and boswellia serata extract. Methods We conducted a randomized, double-blind, placebo-controlled, parallel-group trial from November 1, 2019 to April 3, 2020. The effects of“Fushi-jiman(gel type)”on the knee joints of 66 healthy Japanese adult subjects was examined. Subjects were randomly assigned to groups in which“Fushi-jiman(gel type)”(Fushi-jiman group)or placebo ointment(P group) (n=33 per group)was applied. Randomization was performed using a computerized random number generator. The“Fushi-jiman(gel type)”or placebo ointment was applied twice per day for four weeks. Changes in the total score for the Japanese Knee Osteoarthritis Measure (JKOM; primary outcome), other parameters of the JKOM, and subjective symptoms regarding the quality of life were assessed. Results Data were analyzed with the intention to treat. Each group consisted of 33 subjects. After four-week of intervention, in JKOM, the total score, the visual analog scale of knee pain, and the scores of“General activities”and“Health conditions”significantly improved in the Fushi-jiman group compared to the P group. No adverse events were observed. Conclusions These results suggest that“Fushi-jiman(gel type)”reduces discomfort in the knee joints of healthy Japanese adults. Trial Registration:UMIN-CTR: UMIN000038450 Foundation:YASOUKOUSO Co., Ltd. -
レンコンエキスパウダー摂取による鼻と眼のアレルギー症状軽減効果の検証―プラセボ対照ランダム化二重盲検並行群間比較試験―
48巻9号(2020);View Description
Hide Description
Objectives In this paper, we designed a randomized double-blind placebo-controlled methodology for verifying the clinical effects of a lotus-root extract as antiallergic components. Accordingly, we will report the therapeutic capabilities of the extract against some kind of eye-and nose-corresponding allergy. Methods As the test food, a granular powder(3.0 g/package)containing a lotus-root extract (1.70 g), maltodextrin(1.24 g)and a moisture-proof agent(0.06 g), was used for oral ingestions of the powder to our test volunteers twice a day(total: 6.0 g powder)for 8 weeks. The control experiment was carried out in the same manner, except ingesting the equal amount of a placebo food. Forty healthy volunteers ranging in age from 20-56(nineteen subjects in their 20 s, nine subjects in their 30 s, seven subjects in their 40 s, and five subjects in their 50 s)participated in our clinical trial equipped with the above︱mentioned methodology. We divided them into two groups(n=20): placebo︱control group, 9 men and 11 women(mean age ±SD: 33.5 ±11.5); and test group, 10 men and 10 women(mean age±SD: 32.7 ±10.8). To observe the clinical effects derived by continuous consumption of the test food for 8 weeks, we measured possible primary╱secondly endpoints for eye- and nose-corresponding allergy. Results In order to investigate variations in our volunteersʼ allergic conditions during their continuous consumption of the test food, we compared them to a placebo-control group. To begin with, the nose-related conditions in the test group were better than those in the control group, although no significant difference in the endpoint could be detected. Nevertheless, it was quite obvious that the test-food intake revealed remarkable improvements of our volunteersʼ allergies, especially in eye-related ones(P<0.05). All through this trial, there were no subjects who complained about any kind of side effect. Conclusions We designed a randomized double-blind placebo-controlled methodology, andinvestigated the improvement effects with a lotus-root extract in eye- and nose-related allergic conditions. Our experimental results strongly suggest that daily ingestion of lotus root-derived functional foods can improve some kind of allergic reaction, especially in eye-corresponding one.( UMIN ID: UMIN000038255) -
キウイフルーツ果汁末添加プロテイン飲料の摂取による血中アミノ酸濃度変化に関する検討―ランダム化プラセボ対照二重盲検クロスオーバー比較試験―
48巻9号(2020);View Description
Hide Description
Objective We investigated how adding kiwi fruit juice powder to a whey protein drink impacts blood amino acid levels and defecation status. Methods This 2⊠2 randomized, placebo-controlled, double-blind, crossover trial included healthy Japanese subjects(n=10)who consumed unspecified protein supplements and defecated 3-5 times a week. They were randomly divided into two groups(n=5 per group)using a computerized random-number generator. One group consumed a protein drink including the kiwi fruit juice powder(KFJP consumption-period); the other consumed a protein drink containing a placebo additive(Placebo consumption-period). The subjects consumed their assigned drink daily over a two-week intervention period followed by a one-week washout period. Study outcomes included evaluation of blood amino acid levels and defecation status. Results All 10 subjects completed the study. In the KFJP drink-period, the incremental area under the curve(IAUC)of total blood amino acids was significantly higher than the Placebo drink-period(P<0.05)and a subgroup analysis revealed that the subjects having hard stools initially experienced a significant increase in stool volume two weeks after consuming the KFJP drink(P<0.05). No adverse events relating the test drinks were reported. Conclusions A significant increase in the IAUC of total amino acids was observed for those who ingested whey protein containing kiwi fruit juice powder. Furthermore, subjects reporting hard stools initially, experienced a significant increase in stool volume after two weeks of consuming the whey protein drink containing kiwi fruit juice powder. Trial registration UMIN-CTR: UMIN000039280 Foundation NOF CORPORATION -
凍り豆腐の食後高血糖(血糖値スパイク)抑制効果―ランダム化プラセボ対照単盲検クロスオーバー試験―
48巻9号(2020);View Description
Hide Description
Objectives We evaluated the effect of Kori-tofu on postprandial hyperglycemia. Methods Ninety-two healthy subjects ingested the test food(bread containing Kori -tofu)or the control food(not containing Kori-tofu)alternately. Their blood glucose level was measured by a continues measurement device. Results Postprandial hyperglycemia was observed in 27 subjects. Intake of the test food containing resistant protein significantly suppressed the elevation of blood glucose level in the subjects. Conclusions Intake of Kori-tofu lead to suppression of postprandial hyperglycemia. -
コラーゲン・トリペプチドの動脈硬化症に対する影響―ランダム化二重盲検プラセボ対照並行群間比較試験―
48巻9号(2020);View Description
Hide Description
Objective To investigate the effects of ingestion of collagen tripeptide(CTP)on human arteriosclerosis. Methods We enrolled 42 subjects with hyperlipidemia, hypertension, and/or the pre-stages of these diseases for this randomized, double-blind, placebo-controlled, parallel-group comparison study. Subjects ingested 3.9 g of either CTP or a placebo once daily for 6 months. Body weight, body mass index (BMI), blood pressure, blood lipids, liver function, fasting blood sugar(FBS), pulse wave velocity(PWV), ankle-brachial pressure index(ABI), and intima-media thickness(IMT)were recorded pre-ingestion and 6 months after the first dose. Results Thirty-nine patients completed the study. Almost all had hyperlipidemia (including pre-hyperlipidemia)and about 70% had hypertension(including pre-hypertension). Systolic and diastolic blood pressure(SBP and DBP), triglyceride (TG)levels, and FBS were significantly lower while HDL cholesterol(HDL-C)was significantly higher in the CTP group compared with the placebo group. Although PWV was not significantly different between groups, this parameter improved among subjects in the CTP group with high PWV. Multiple regression analysis revealed ingestion of CTP to be an independent factor affecting SBP, DBP, and, HDL-C, and FBS. Furthermore, TG showed a tendency to be related to ingestion of CTP. Conclusion Ingestion of CTP contributes to the improvement of multiple risk factors for arteriosclerosis; therefore, CTP could be beneficial as a dietary supplement for the management of arteriosclerosis. (UMIN-ID:000023186) -
Effects of Maltobionic Acid on Bowel Movement in Healthy Japanese Adult Women with Mild Constipation―A Randomized Double—blind Placebo—controlled Crossover Study―
48巻9号(2020);View Description
Hide Description
Background/Objective This study investigated the effects of maltobionic acid (maltobionic acid syrup)ingestion on bowel movement in healthy Japanese adult women with mild constipation. Methods This was a randomized, double-blind, placebo-controlled, crossover trial. Twenty healthy Japanese adult women with mild constipation were categorized into three groups: MB syrup 4 g group maltobionic acid syrup 4 g), MB syrup 2 g group(maltobionic acid syrup 2 g, maltose syrup 2 g), and Placebo group(maltose syrup 4 g). Defecation days, stool volume, Constipation Assessment Scale Middle Term version(CAS-MT), and Bristol stool scale were used to assess the efficacy of the intervention in terms of improving bowel movements. Results No dropouts or adherence violations occurred during the intervention period, and all 20 subjects completed the study. Compared to placebo intake, continuous ingestion of≥2 g of maltobionic acid syrup(equivalent to≥0.8 g of maltobionic acid)significantly improved bowel movement indicators defecation days, fecal amount, CAS score, and Bristol stool scale score, confirming the efficacy of the intervention. Conclusions Maltobionic acid is known to be rarely absorbed in the small intestine, reached the large intestine and used by intestinal bacteria which produces short-chain fatty acids and organic acids. As a result, these metabolites were considered to have contributed to the improvement of various defecation indicators by activating intestinal peristalsis.(UMIN-CTRID: 000039225) -
パッションフルーツ種子エキスの健常成人における長期摂取安全性試験―オープン試験―
48巻9号(2020);View Description
Hide Description
Objective The aim of this study was to evaluate the safety of long-term oral intake of passion fruit seeds extract on healthy subjects. Methods An open-label study was conducted in 20 healthy subjects(20-64 years old). The subjects were given the test product(125 mL drink containing 10 mg piceatannol derived from passion fruit seeds extract)3 times per day for 90 days. Physical examination, blood analysis, urinalysis, and a medical questionnaire were examined. Results 11 out of 20 subjects were included in the final analysis. No abnormal changes were observed in physical examination, blood analysis, or urinalysis. No adverse events attributed to the test drink were observed during the study. Conclusions These results demonstrated that long-term oral intake of drink containing 30 mg piceatannol derived from passion fruit seeds extract was safe.(UMIN-CTR000039098) -
健常成人を対象としたクエン酸塩混合物シトレートケミファ221 含有食品によるストレスと睡眠に関する改善効果―ランダム化二重盲検プラセボ対照並行群間比較試験―
48巻9号(2020);View Description
Hide Description
Background Intake of tripotassium citrate, trisodium citrate, and citric acid (hereafter collectively referred to as citrate)are suggested to improve quality of sleep and moods. Objectives The purpose of this study was to examine the effects of citrate on quality of sleep and mood in healthy people(those who do not have the disease). Methods Citrate(3000 mg/day)was continuously ingested for 14 days in Japanese men and women aged 20-65 who were unsatisfied with sleep, and the St. Mary Hospital sleep questionnaire, heart rate, sleep time, and POMS2, etc. as an index of objective and subjective sleep quality were investigated by a randomized, double-blind, placebo-controlled, parallel-group comparative study. Results Compared with the control group, the citrate intake group showed a significant increase in the refreshing degree upon waking up, a significant increase in the total sleep time, a significant decrease in the awakening frequency, and a significant decrease in the pulse rate (comparison between groups). In addition, there was a significant decrease in the POMS2 fatigue-inertia(FI)score, a significant decrease in the tension-anxiety(TA)score, and a significant decrease in the total mood disturbance(TMD)score in women(comparison between groups). Conclusions Oral intake of 3000 mg of citrate╱day was shown to improve sleep quality in healthy adults and mood in healthy adult women.(UMIN000037893) -
β—カロテン摂取が軽症から中等症の通年性アレルギー性鼻炎症状に与える影響―ランダム化二重盲検プラセボ対照並行群間比較試験―
48巻9号(2020);View Description
Hide Description
Objective To clarify the effects of β-carotene on the symptoms of perennial allergic rhinitis (PAR)in subjects with mild to moderate symptoms, a randomized, double-blind, placebo-controlled, parallel-group comparative study was conducted. Methods Forty subjects with mild to moderate PAR symptoms were randomly divided into two groups and ingested a mixed vegetable and fruit juice containing β-carotene(β-carotene group)or a placebo juice(placebo group)for 8 weeks. The symptoms of PAR were assessed by Japanese allergic rhinitis standard quality of life questionnaire(JRQLQ)and classification of the severity of allergic rhinitis symptoms. The serum concentrations of β-carotene were measured by HPLC. Results JRQLQ symptoms scores of“watery eyes”at week 8,“eye symptoms”at week 6 and 8, and“nasal and eye symptoms”at week 6 were significantly lower in β-carotene group than in placebo group. In quality of life(QOL)scores of JRQLQ“, daily life”score at week 8 was also significantly lower in β-carotene group than in placebo group. The serum concentration of β-carotene at week 4 and 8 were significantly higher in β-carotene group than in placebo group. Conclusions These results suggest that β-carotene could improve nasal and eye symptoms of PAR and QOL in subjects with mild to moderate symptoms. (UMIN ID:UMIN 000034060) -
The Effect of the Intake of a Hydrogen—rich Jelly Supplement on the Quality of Sleep in Healthy Female Adults―A Randomized Double—blind Placebo—controlled Parallel—group Trial―
48巻9号(2020);View Description
Hide Description
Background The aim of this study is to determine the effect of a Hydrogen-rich jelly supplement on the sleep quality of healthy female adults. Method A clinical trial was conducted with 29 female adults who felt stressed but generally healthy randomly assigned to either a Hydrogen rich jelly supplement group, or a placebo group. It was confirmed that sleep quality was enhanced when taking the Hydrogen rich jelly supplement. Result The intake of Hydrogen-rich jelly supplement had a significant effect on sleep length over 4 weeks. In addition, there was a significant interaction(group×before-and-after test)in hydration level of the skin. Conclusion Overall, the effect of Hydrogen-rich jelly supplement on sleep length in healthy female adults was observed. Our results may suggest that daily intake of the Hydrogen-rich jelly supplement prevents sleep disturbances by reducing oxidative stress. (UMIN000038533)
-
-
COLUMN
-
-
-
INFORMATION
-
-
-
CONSORT 2010声明—ランダム化並行群間比較試験報告のための最新版ガイドライン—(薬理と治療2010;38:939-49.より再掲載)
48巻9号(2020);View Description
Hide Description
-
-
-